Showing results (211-220 of 289) with videos related to
Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Phase II study of doxifluridine in advanced colorectal adenocarcinomaR Abele, P Alberto, S Kaplan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKKC Hürny, J Bernhard, R Joss, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
Chronic oral etoposide in small-cell lung cancer: clinical and pharmacokinetic resultsC Sessa, M Zucchetti, V Torri, et al.European Journal of Cancer & Clinical Oncology|February 1, 1984
Phase II study of 9-hydroxy-2N-methylellipticinium acetateA Clarysse, A Brugarolas, P Siegenthaler, et al.European Journal of Cancer & Clinical Oncology|February 1, 1988
Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG)M van Glabbeke, J Renard, H M Pinedo, et al.Journal of the National Cancer Institute|August 21, 1991
Phase I and clinical pharmacological evaluation of aphidicolin glycinateC Sessa, M Zucchetti, E Davoli, et al.Schweizerische Medizinische Wochenschrift|October 26, 1985
[Clinical characteristics of immature T-type (negative E-rosette) acute lymphoblastic leukemia detected by LAU-A1 monoclonal antibody]V von Fliedner, J P Grob, D Heumann, et al.Cancer|October 15, 1984
Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neckM Rozencweig, P Dodion, U Bruntsch, et al.Blood|January 1, 1980
Combination chemotherapy for terminal-phase chronic granulocytic leukemia: cancer and leukemia group B studiesM Coleman, R T Silver, T F Pajak, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Phase I study of the novel distamycin derivative tallimustine (FCE 24517)C Sessa, O Pagani, M G Zurlo, et al.Pageof 29